BridgeBio Oncology Therapeutics
(NASDAQ) BBOT
BridgeBio Oncology Therapeutics Financials at a Glance
Market Cap
$592.79M
Revenue (TTM)
$0.00
Net Income (TTM)
-$154.10M
EPS (TTM)
-$527.59
P/E Ratio
-0.01
Dividend
$0.00
Beta (Volatility)
2.09 (High)
Dividend
$0.00
Beta (Volatility)
2.09 (High)
Price
$7.64
Volume
235,826.879
Open
$7.41
Price
$7.64
Volume
235,826.879
Open
$7.41
Previous Close
$7.66
Daily Range
$7.29 - $7.67
52-Week Range
$7.00 - $14.87
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
2.09 (High)
Price
$7.64
Volume
235,826.879
Open
$7.41
Previous Close
$7.66
Daily Range
$7.29 - $7.67
52-Week Range
$7.00 - $14.87
Estimated Earnings Date
Aug 11, 2026
BBOT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BridgeBio Oncology Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
92
CEO
Eli M. Wallace, PhD
Website
bbotx.comHeadquarters
South San Francisco, CA 94080, US
BBOT Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-61.49%
Return on Capital
-35.23%
Return on Assets
-36.90%
Earnings Yield
-100.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$592.79M
Shares Outstanding
80.11M
Volume
235.83K
Avg. Volume
450.51K
Financials (TTM)
Gross Profit
-$186.00K
Operating Income
-$168.86M
EBITDA
-$168.12M
Operating Cash Flow
-$172.07M
Capital Expenditure
-$861.00K
Free Cash Flow
-$172.93M
Cash & ST Invst.
$252.28M
Total Debt
$2.64M
BridgeBio Oncology Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$186.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$592.79M
N/A
Market Cap/Employee
$9.56M
N/A
Employees
62
N/A
Net Income
-$42.11M
-90.9%
EBITDA
-$45.99M
-99.3%
Quarterly Fundamentals
Total Cash
$252.28M
+85.9%
Total Debt
$2.64M
-0.2%
Accounts Receivable
$146.00K
+265.0%
Inventory
$0.00
N/A
Long Term Debt
$2.11M
-20.3%
Short Term Debt
$538.00K
+8866.7%
Return on Assets
-36.90%
N/A
Return on Invested Capital
-45.10%
N/A
Free Cash Flow
-$35.94M
-4792.3%
Operating Cash Flow
-$35.92M
-4789.0%